These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1964640)

  • 1. Reduced technetium 99m labelled NCA-95/CEA-antibody uptake in liver due to gentle antibody reconstitution. Technical note.
    Reske SN; Buell U
    Eur J Nucl Med; 1990; 17(1-2):38-41. PubMed ID: 1964640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of bone marrow immunoscintigraphy using a Tc-99m labeled anti-NCA-95 monoclonal antibody.
    Choi CW; Chung JK; Lee DS; Lee MC; Chung HK; Kim BK; Koh CS
    Nucl Med Biol; 1995 Jan; 22(1):117-23. PubMed ID: 7735161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunochemical identification of an alpha 1-acid glycoprotein-antigenic determinant on carcinoembryonic antigen (CEA) and non-specific cross-reacting antigen (NCA).
    Ochi Y; Ura Y; Hamazu M; Fujiyama Y; Kajita Y; Ishida M; Miyazaki T; Tamura K
    Clin Chim Acta; 1984 Mar; 138(1):9-19. PubMed ID: 6201306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell adhesion activity of non-specific cross-reacting antigen (NCA) and carcinoembryonic antigen (CEA) expressed on CHO cell surface: homophilic and heterophilic adhesion.
    Oikawa S; Inuzuka C; Kuroki M; Matsuoka Y; Kosaki G; Nakazato H
    Biochem Biophys Res Commun; 1989 Oct; 164(1):39-45. PubMed ID: 2803308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone marrow scintigraphy with 99m Tc labelled monoclonal anti-NCA 90 Fab' fragment: a feasibility study and comparison of bone marrow uptake with 99m Tc labelled monoclonal anti-NCA 95 antigranulocyte antibody.
    Ivancevic V; Huic D; Wolter A; Munz DL
    Nucl Med Commun; 2002 Mar; 23(3):249-55. PubMed ID: 11891483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo labelling of granulocytes with 99mTc anti-NCA monoclonal antibodies for imaging inflammation.
    Joseph K; Höffken H; Bosslet K; Schorlemmer HU
    Eur J Nucl Med; 1988; 14(7-8):367-73. PubMed ID: 3181186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radioimmunoimaging for diagnosis of bone marrow involvement in breast cancer and malignant lymphoma.
    Reske SN; Karstens JH; Gloeckner W; Steinsträsser A; Schwarz A; Ammon J; Buell U
    Lancet; 1989 Feb; 1(8633):299-301. PubMed ID: 2563458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibody against carcinoembryonic antigen (CEA) identifies two new forms of crossreacting antigens of molecular weight 90,000 and 160,000 in normal granulocytes.
    Audette M; Buchegger F; Schreyer M; Mach JP
    Mol Immunol; 1987 Nov; 24(11):1177-86. PubMed ID: 3320743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epitopes of carcinoembryonic antigen (CEA) defined by monoclonal antibodies.
    Price MR
    Br J Cancer; 1988 Feb; 57(2):165-9. PubMed ID: 2451932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 99mTc-labeled chimeric anti-NCA 95 antigranulocyte monoclonal antibody for bone marrow imaging.
    Sarwar M; Higuchi T; Tomiyoshi K; Inoue T; Oriuchi N; Kbalil A; Alyafei S; Sakahara H; Chung JK; Endo K
    Radiat Med; 1998; 16(5):391-7. PubMed ID: 9862166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of monoclonal antibodies against the non-specific cross-reacting antigen (NCA).
    Chavanel G; Frenoy N; Escribano MJ; Burtin P
    Oncodev Biol Med; 1983; 4(3):209-17. PubMed ID: 6402767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on circulating antibody against carcinoembryonic antigen (CEA) and CEA-like antigen in cancer patients.
    Ura Y; Ochi Y; Hamazu M; Ishida M; Nakajima K; Watanabe T
    Cancer Lett; 1985 Jan; 25(3):283-95. PubMed ID: 2578868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoscintigraphy using a technetium-99m labelled monoclonal anti-CEA antibody in the follow-up of colorectal cancer and other tumours producing CEA.
    Hertel A; Baum RP; Lorenz M; Baew-Christow T; Encke A; Hör G
    Br J Cancer Suppl; 1990 Jul; 10():34-6. PubMed ID: 2166552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different biodistribution of 99mTc-labelled chimeric mouse-human monoclonal antibody between athymic mice model and human.
    Oriuchi N; Watanabe N; Sugiyama S; Higuchi T; Imai K; Yamanaka H; Hashimoto M; Kanda H; Endo K
    Br J Cancer; 1996 Jun; 73(12):1466-72. PubMed ID: 8664114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetic data of in-vivo labeled granulocytes in humans with a murine Tc-99m-labelled monoclonal antibody.
    Becker W; Borst U; Fischbach W; Pasurka B; Schäfer R; Börner W
    Eur J Nucl Med; 1989; 15(7):361-6. PubMed ID: 2776795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiolabelled granulocytes in inflammatory bone disease.
    D'Amico P; Lastoria S; Caccavella N; Salvatore M
    Int J Rad Appl Instrum B; 1991; 18(1):145-7. PubMed ID: 1849127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photopenic lesions in bone marrow scintigraphy using technetium-99m labeled antigranulocyte antibody without known tumour.
    Krause T; Reinhardt M; Nitzsche E; Moser E
    Nuklearmedizin; 1999 Apr; 38(3):85-9. PubMed ID: 10320994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural antibodies against the carcinoembryonic antigen (CEA) and a related antigen, NCA, in human sera.
    Frénoy N; Schauffler J; Cahour A; Burtin P
    Anticancer Res; 1987; 7(6):1229-33. PubMed ID: 3327450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow scintigraphy with technetium-99m anti-NCA-95 to monitor therapy in malignant osteopetrosis.
    Thelen MH; Eschmann SM; Moll-Kotowski M; Dopfer R; Bares R
    J Nucl Med; 1998 Jun; 39(6):1033-5. PubMed ID: 9627340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production kinetics and immunochemical properties of carcinoembryonic antigen and nonspecific cross-reacting antigen synthesized by various human tumor cell lines.
    Ichiki S; Kuroki M; Kuroki M; Koga Y; Matsuoka Y
    Jpn J Cancer Res; 1986 May; 77(5):462-72. PubMed ID: 2426231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.